Efficacy of Topical Brinzolamide Treatment in Posterior Microphthalmos-Related Macular Cystoid Lesions: A Case Series

Simple item page
dc.contributor.authorEngin, CD
dc.contributor.authorEkinci, UB
dc.contributor.authorSelver, A
dc.contributor.authorSaatci, AO
dc.date.accessioned2024-07-18T12:02:43Z
dc.date.available2024-07-18T12:02:43Z
dc.description.abstractThe aim of this study was to report the outcome of topical brinzolamide 1% treatment on macular cystoid lesions resembling retinoschisis in 4 patients diagnosed with posterior microphthalmia. The medical records of 4 patients with a clinical diagnosis of posterior microphthalmia who had started topical brinzolamide 1% treatment were reviewed. Visual acuity, central foveal thickness, and cystoid lesion area percentage were used to evaluate treatment response. In the follow-up, there was a decrease in central foveal thicknesses and cystoid lesion area percentages in both eyes of 3 of the patients. However, 1 patient showed increases in both parameters. Visual acuity remained stable in 5 eyes and increased in 3 eyes. Topical brinzolamide treatment may have some positive effects on macular cystoid lesions in selected cases.
dc.identifier.issn1300-0659
dc.identifier.other2147-2661
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/8640
dc.language.isoEnglish
dc.publisherTURKISH OPHTHALMOLOGICAL SOC
dc.subjectPAPILLOMACULAR FOLD
dc.subjectCARBONIC-ANHYDRASE
dc.subjectDORZOLAMIDE
dc.subjectRETINOSCHISIS
dc.subjectMANAGEMENT
dc.subjectFEATURES
dc.subjectEDEMA
dc.titleEfficacy of Topical Brinzolamide Treatment in Posterior Microphthalmos-Related Macular Cystoid Lesions: A Case Series
dc.typeArticle

Files

Collections

Web of Science Koleksiyonu